Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of...
Guardado en:
Autor principal: | |
---|---|
Otros Autores: | , , |
Formato: | Electrónico Capítulo de libro |
Lenguaje: | inglés |
Publicado: |
Frontiers Media SA
2018
|
Colección: | Frontiers Research Topics
|
Materias: | |
Acceso en línea: | DOAB: download the publication DOAB: description of the publication |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!